Interferons as biomarkers and effectors: lessons learned from animal models

Cassandra M Berry, Paul John Hertzog, Niamh Mangan

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

Interferons (IFNs) comprise type I, II and III families with multiple subtypes. Via transcription of IFN-stimulated genes (ISGs), IFNs can exert multiple biological effects on the cell. In infectious and chronic inflammatory diseases, the IFNs and their ISG sets can be potentially utilized as biomarkers of disease outcome. Animal models allow investigations into disease pathogenesis and gene knockout models have proved cause and effect relationships of molecules related to the IFN response. Sets of IFN subtypes and their ISG products provide immunological signature patterns for different viral and other diseases. In this article, we give an overview of IFNs in several virus infection models and autoimmune diseases of medical relevance. Lessons learned from animal models inform us of IFN system parameters as indicators of disease outcome and whether clinical research is warranted. Moreover, validated IFN biomarkers for prognosis enhance our understanding of therapeutic and vaccine development.
Original languageEnglish
Pages (from-to)159 - 176
Number of pages18
JournalBiomarkers in Medicine
Volume6
Issue number2
DOIs
Publication statusPublished - 2012

Cite this

@article{8e9fc8337a7f41b39af89bdd97dc1534,
title = "Interferons as biomarkers and effectors: lessons learned from animal models",
abstract = "Interferons (IFNs) comprise type I, II and III families with multiple subtypes. Via transcription of IFN-stimulated genes (ISGs), IFNs can exert multiple biological effects on the cell. In infectious and chronic inflammatory diseases, the IFNs and their ISG sets can be potentially utilized as biomarkers of disease outcome. Animal models allow investigations into disease pathogenesis and gene knockout models have proved cause and effect relationships of molecules related to the IFN response. Sets of IFN subtypes and their ISG products provide immunological signature patterns for different viral and other diseases. In this article, we give an overview of IFNs in several virus infection models and autoimmune diseases of medical relevance. Lessons learned from animal models inform us of IFN system parameters as indicators of disease outcome and whether clinical research is warranted. Moreover, validated IFN biomarkers for prognosis enhance our understanding of therapeutic and vaccine development.",
author = "Berry, {Cassandra M} and Hertzog, {Paul John} and Niamh Mangan",
year = "2012",
doi = "10.2217/BMM.12.10",
language = "English",
volume = "6",
pages = "159 -- 176",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine",
number = "2",

}

Interferons as biomarkers and effectors: lessons learned from animal models. / Berry, Cassandra M; Hertzog, Paul John; Mangan, Niamh.

In: Biomarkers in Medicine, Vol. 6, No. 2, 2012, p. 159 - 176.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Interferons as biomarkers and effectors: lessons learned from animal models

AU - Berry, Cassandra M

AU - Hertzog, Paul John

AU - Mangan, Niamh

PY - 2012

Y1 - 2012

N2 - Interferons (IFNs) comprise type I, II and III families with multiple subtypes. Via transcription of IFN-stimulated genes (ISGs), IFNs can exert multiple biological effects on the cell. In infectious and chronic inflammatory diseases, the IFNs and their ISG sets can be potentially utilized as biomarkers of disease outcome. Animal models allow investigations into disease pathogenesis and gene knockout models have proved cause and effect relationships of molecules related to the IFN response. Sets of IFN subtypes and their ISG products provide immunological signature patterns for different viral and other diseases. In this article, we give an overview of IFNs in several virus infection models and autoimmune diseases of medical relevance. Lessons learned from animal models inform us of IFN system parameters as indicators of disease outcome and whether clinical research is warranted. Moreover, validated IFN biomarkers for prognosis enhance our understanding of therapeutic and vaccine development.

AB - Interferons (IFNs) comprise type I, II and III families with multiple subtypes. Via transcription of IFN-stimulated genes (ISGs), IFNs can exert multiple biological effects on the cell. In infectious and chronic inflammatory diseases, the IFNs and their ISG sets can be potentially utilized as biomarkers of disease outcome. Animal models allow investigations into disease pathogenesis and gene knockout models have proved cause and effect relationships of molecules related to the IFN response. Sets of IFN subtypes and their ISG products provide immunological signature patterns for different viral and other diseases. In this article, we give an overview of IFNs in several virus infection models and autoimmune diseases of medical relevance. Lessons learned from animal models inform us of IFN system parameters as indicators of disease outcome and whether clinical research is warranted. Moreover, validated IFN biomarkers for prognosis enhance our understanding of therapeutic and vaccine development.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22448790

U2 - 10.2217/BMM.12.10

DO - 10.2217/BMM.12.10

M3 - Article

VL - 6

SP - 159

EP - 176

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 2

ER -